Recursion Pharmaceuticals is trading at $4.20, up 4.09% as of 10:19 a.m. EDT on September 30, 2026; no fresh company-specific announcement or confirmed catalyst was found.

  • The supplied snapshot shows the Nasdaq up 0.90% and the S&P 500 up 0.59%. The positive market backdrop may have contributed, but reporting does not directly attribute the gain to the rally.
  • Recent pipeline and partnership coverage predates this session.